| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. | PRINCIPAL ACCOUNTING OFFICER | Stock Option (right to buy) | 24,000 | 01 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | 01 Jan 2023 | 1 | $0 | 4 | PRINCIPAL ACCOUNTING OFFICER | 04 Jan 2023, 15:09 |
| XLO | Xilio Therapeutics, Inc. | 09 Nov 2022 | 0 | $0 | 3 | Principal Accounting Officer | 16 Nov 2022, 15:16 |